Year |
Citation |
Score |
2020 |
Krystal AD, Pizzagalli DA, Smoski M, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu D, Murrough JW, Yang H, Weiner RD, Calabrese JR, Sanacora G, Hermes G, Keefe RSE, Song A, ... ... Szabo ST, et al. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. Nature Medicine. PMID 32231295 DOI: 10.1038/S41591-020-0806-7 |
0.318 |
|
2019 |
Mischel NA, Kritzer MD, Patkar AA, Masand PS, Szabo ST. Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the Clinician. Journal of Clinical Psychopharmacology. 39: 665-672. PMID 31688400 DOI: 10.1097/Jcp.0000000000001132 |
0.342 |
|
2019 |
Banov MD, Young JR, Dunn T, Szabo ST. Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. Cns Spectrums. 1-12. PMID 31339086 DOI: 10.1017/S1092852919001238 |
0.33 |
|
2018 |
Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Medicine Reviews. 43: 23-36. PMID 30503715 DOI: 10.1016/J.Smrv.2018.09.006 |
0.42 |
|
2013 |
Kumar S, Black SJ, Hultman R, Szabo ST, DeMaio KD, Du J, Katz BM, Feng G, Covington HE, Dzirasa K. Cortical control of affective networks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 1116-29. PMID 23325249 DOI: 10.1523/Jneurosci.0092-12.2013 |
0.33 |
|
2012 |
Lee TH, Szabo ST, Fowler JC, Mannelli P, Mangum OB, Beyer WF, Patkar A, Wetsel WC. Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy. Drug and Alcohol Dependence. 124: 11-8. PMID 22356892 DOI: 10.1016/J.Drugalcdep.2012.01.021 |
0.396 |
|
2011 |
Bhatia KS, Szabo ST, Fowler JC, Wetsel WC, Lee TH. Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine. Behavioural Brain Research. 223: 227-32. PMID 21571009 DOI: 10.1016/J.Bbr.2011.04.045 |
0.381 |
|
2009 |
Szabo ST, Machado-Vieira R, Yuan P, Wang Y, Wei Y, Falke C, Cirelli C, Tononi G, Manji HK, Du J. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology. 56: 47-55. PMID 18789340 DOI: 10.1016/J.Neuropharm.2008.08.015 |
0.312 |
|
2007 |
Einat H, Yuan P, Szabo ST, Dogra S, Manji HK. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology. 55: 123-31. PMID 17641532 DOI: 10.1159/000106054 |
0.302 |
|
2005 |
Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. The Journal of Clinical Psychiatry. 66: 30-40. PMID 16336034 |
0.524 |
|
2004 |
Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST, Einat H, Manji HK. Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6578-89. PMID 15269270 DOI: 10.1523/Jneurosci.1258-04.2004 |
0.31 |
|
2004 |
Szabo ST, Gold MS, Goldberger BA, Blier P. Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biological Psychiatry. 55: 934-9. PMID 15110737 DOI: 10.1016/J.Biopsych.2003.12.013 |
0.537 |
|
2002 |
Szabo ST, Blier P. Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons. The Journal of Pharmacology and Experimental Therapeutics. 302: 983-91. PMID 12183655 DOI: 10.1124/Jpet.102.033282 |
0.592 |
|
2001 |
Szabo ST, Blier P. Response of the norepinephrine system to antidepressant drugs. Cns Spectrums. 6: 679-84. PMID 15520619 DOI: 10.1017/S1092852900001371 |
0.545 |
|
2001 |
Blier P, Haddjeri N, Szabo ST, Dong J. Enhancement of serotoninergic function - a sometimes insufficient cause of antidepressant action. Human Psychopharmacology. 16: 23-27. PMID 12404594 DOI: 10.1002/Hup.179 |
0.446 |
|
2001 |
Szabo ST, Blier P. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 845-57. PMID 11750178 DOI: 10.1016/S0893-133X(01)00284-6 |
0.577 |
|
2001 |
Szabo ST, Blier P. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus. Synapse (New York, N.Y.). 42: 203-12. PMID 11746719 DOI: 10.1002/Syn.10009 |
0.56 |
|
2001 |
Szabo ST, Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Research. 922: 9-20. PMID 11730697 DOI: 10.1016/S0006-8993(01)03121-3 |
0.572 |
|
2001 |
Szabo ST, Blier P. Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biological Psychiatry. 50: 644-6. PMID 11690604 DOI: 10.1016/S0006-3223(01)01260-4 |
0.47 |
|
2001 |
Szabo ST, Blier P. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. The European Journal of Neuroscience. 13: 2077-87. PMID 11422448 DOI: 10.1046/J.0953-816X.2001.01583.X |
0.582 |
|
2000 |
Szabo ST, de Montigny C, Blier P. Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 3: 1-11. PMID 11343573 DOI: 10.1017/S1461145700001772 |
0.59 |
|
2000 |
Haddjeri N, Szabo ST, de Montigny C, Blier P. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 346-56. PMID 10700654 DOI: 10.1016/S0893-133X(99)00138-4 |
0.587 |
|
1999 |
Szabo ST, de Montigny C, Blier P. Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. British Journal of Pharmacology. 126: 568-71. PMID 10188964 DOI: 10.1038/Sj.Bjp.0702343 |
0.583 |
|
Show low-probability matches. |